ITEMS IN AFP WITH KEYWORD:

Family Planning and Contraception

Sep 1, 2018 Issue
Long-Acting Reversible Contraception: Difficult Insertions and Removals [Article]

Although most long-acting reversible contraception insertions and removals are straightforward, with the rise in the use of intrauterine devices and implants, clinicians are more likely to encounter challenges with these procedures. Learn strategies for managing difficult cases.


Aug 1, 2018 Issue
Treatment Duration for Etonogestrel Implant [FPIN's Help Desk Answers]

The etonogestrel subdermal implant is approved by the U.S. Food and Drug Administration for contraception for up to three years, but it seems to be effective for up to five years.


Jan 1, 2018 Issue
Immediate Postpartum LARC: An Underused Contraceptive Option [Editorials]

Providing immediate postpartum LARC to women who want it is an evidence-based, patient-centered, and safe practice.


Dec 1, 2017 Issue
Local Anesthesia for IUD Insertion or Endometrial Biopsy [FPIN's Help Desk Answers]

Topical application of lidocaine/prilocaine cream to the cervix reduces mean pain scores during IUD insertion. Intrauterine instillation of liquid anesthesia reduces median pain scores during endometrial biopsy.


Jun 1, 2017 Issue
Hormonal Contraceptives in Women Who Are Overweight or Obese [FPIN's Help Desk Answers]

Hormonal contraceptives (oral contraceptive pills, implants, patches, and rings) are highly effective in women of all weights.There is no consistently demonstrated increased risk of pregnancy in overweight women using any specific hormonal method of contraception.


Apr 1, 2017 Issue
Preventing Unintended Adolescent Pregnancy [Cochrane for Clinicians]

Among adolescents, educational interventions increase reported condom use at most recent intercourse, whereas contraceptive-promoting interventions increase use of hormonal contraception.


Jan 15, 2017 Issue
CDC Updates Recommendations for Contraceptive Use [Practice Guidelines]

The Centers for Disease Control and Prevention (CDC) first published the U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) in 2013 to provide direction for safe and effective use of contraceptive methods. These guidelines update the 2013 report.


Dec 1, 2016 Issue
CDC Updates Eligibility Criteria for Contraceptive Use [Practice Guidelines]

The Centers for Disease Control and Prevention (CDC) first published the U.S. Medical Eligibility Criteria for Contraceptive Use, which is a companion document to the U.S. Selected Practice Recommendations for Contraceptive Use, in 2010 to provide guidelines on safely using a variety of contraceptiv...


Nov 1, 2016 Issue
The Risk of MI and Ischemic Stroke with Combined Oral Contraceptives [Cochrane for Clinicians]

The overall risk of MI and ischemic stroke is increased in women who use combined oral contraceptives. The relative risk of MI and ischemic stroke increases as estrogen dose rises, increasing by 60% with doses of 20 mcg and more than doubling when doses of 50 mcg or more are used.


Oct 15, 2016 Issue
Third-Generation Oral Contraceptives Associated with Greater Risk of PE, Stroke, and MI [POEMs]

Although there is risk with any current oral contraceptive combination, those that contain lower doses of estrogen, and levonorgestrel instead of desogestrel or gestodene, are associated with the least risk of ischemic stroke, myocardial infarction (MI), or pulmonary embolism (PE). These safer products are older so are often less expensive.


Pages: 1 2 3 4 5 6 7 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now